XML 15 R4.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Statement of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Operating expenses:        
Research and development $ 19,271 $ 10,915 $ 41,841 $ 32,608
General and administrative (including related party amounts of $0, $173, $0 and $570, respectively) 4,692 2,730 12,470 11,301
Total operating expenses 23,963 13,645 54,311 43,909
Loss from operations (23,963) (13,645) (54,311) (43,909)
Other income (expense):        
Interest income 2,816 1,131 8,035 1,496
Other income (expense) (5) 5 (28) (17)
Total other income (expense), net 2,811 1,136 8,007 1,479
Net loss and comprehensive loss $ (21,152) $ (12,509) $ (46,304) $ (42,430)
Net loss per share, basic $ (0.49) $ (0.3) $ (1.09) $ (1.02)
Net loss per share, diluted $ (0.49) $ (0.3) $ (1.09) $ (1.02)
Weighted - average shares used to compute net loss per common share - basic 42,868,340 41,997,195 42,619,075 41,777,052
Weighted - average shares used to compute net loss per common share - diluted 42,868,340 41,997,195 42,619,075 41,777,052